Received: 13 July 2021
Accepted: 4 October 2022
First Online: 11 December 2022
: The LEGEND-2 study was performed in accordance with the Declaration of Helsinki and was approved by the institutional independent ethics committee (Reference number: 2016002) of The Second Affiliated Hospital of Xi’an Jiaotong University. The patient has consented and agreed to publication and images included within the case report.
: Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
: Q-CZ and FF are employees of Nanjing Legend Biotech Co. All other authors declare no competing interests.